durvalumab
astrazeneca
['sclc', 'durvalumab', 'nsclc']
#asco22 dr. also discussed phase i study of radiation with durvalumab in nsclc by dr. . safety reassuring but some feasibility challenges. when is it appropriate or better to omit chemotherapy? 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him